🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 2 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
18/07/2022 43,14 43,96 40,86 41,27 -3,57% 7,19% 709.200
15/07/2022 42,65 42,87 41,16 42,80 +2,74% 4,01% 731.100
14/07/2022 42,18 42,61 41,19 41,66 -2,85% 3,37% 655.400
13/07/2022 40,34 43,68 39,57 42,88 +3,33% 10,19% 689.600
12/07/2022 40,52 41,86 38,87 41,50 +2,98% 7,38% 608.600
11/07/2022 41,19 43,00 39,62 40,30 -3,43% 8,21% 741.200
08/07/2022 41,43 42,14 40,90 41,73 -1,04% 2,99% 599.300
07/07/2022 40,00 43,45 39,57 42,17 +5,45% 9,70% 1.168.100
06/07/2022 39,22 40,71 38,88 39,99 +2,12% 4,67% 1.008.600
05/07/2022 35,90 39,20 35,51 39,16 +8,90% 10,28% 936.400
01/07/2022 35,40 36,65 34,81 35,96 +2,13% 5,20% 731.800
30/06/2022 33,85 35,78 33,00 35,21 +1,88% 8,21% 963.200
29/06/2022 32,43 34,80 31,45 34,56 +6,44% 10,31% 877.400
28/06/2022 33,74 34,33 32,10 32,47 -3,71% 6,62% 737.100
27/06/2022 34,65 35,00 32,89 33,72 -2,15% 6,09% 782.300
24/06/2022 35,00 35,11 32,87 34,46 +0,58% 6,40% 1.842.900
23/06/2022 31,75 34,30 31,68 34,26 +8,52% 8,25% 909.700
22/06/2022 29,80 32,34 29,77 31,57 +3,20% 8,62% 769.300
21/06/2022 29,73 31,27 29,61 30,59 +5,05% 5,58% 943.900
17/06/2022 28,37 30,51 28,37 29,12 +4,79% 7,55% 2.432.900
16/06/2022 27,92 28,56 27,02 27,79 -4,80% 5,52% 1.084.800
15/06/2022 28,17 29,48 27,62 29,19 +4,66% 6,60% 1.033.800
14/06/2022 28,40 28,60 26,81 27,89 -1,38% 6,30% 1.039.900
13/06/2022 29,27 29,77 27,83 28,28 -7,34% 6,63% 876.900
10/06/2022 31,79 31,88 29,69 30,52 -6,06% 6,89% 803.800
09/06/2022 33,50 33,81 32,44 32,49 -4,44% 4,09% 657.300
08/06/2022 34,63 35,70 33,80 34,00 -2,55% 5,49% 621.800
07/06/2022 32,39 35,12 32,39 34,89 +5,86% 8,43% 765.100
06/06/2022 35,73 35,73 32,61 32,96 -5,45% 8,75% 624.300
03/06/2022 33,97 35,01 33,45 34,86 +3,26% 4,59% 655.300